Jul 21, 2026 09:18AM
Jul 21, 2026 09:17AM
Jun 1, 2026 07:01AM
Jun 1, 2026 07:00AM
May 26, 2026 08:00AM
May 26, 2026 08:00AM
May 15, 2026 04:30PM Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
May 15, 2026 04:30PM
May 5, 2026 08:00PM
Apr 29, 2026 08:00AM
Apr 24, 2026 04:30PM
Apr 24, 2026 04:30PM
Apr 24, 2026 08:00AM
Apr 24, 2026 08:00AM Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
Mar 31, 2026 09:13AM
Mar 31, 2026 09:11AM
Mar 24, 2026 08:00AM
Mar 10, 2026 08:47AM
Mar 10, 2026 08:47AM
Mar 4, 2026 09:15AM
Mar 4, 2026 09:15AM Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR‑T Therapy in High‑Risk Diffuse Large B‑Cell Lymphoma
Feb 24, 2026 08:00AM
Feb 13, 2026 08:00AM
Feb 13, 2026 08:00AM
Feb 11, 2026 08:02AM
Feb 11, 2026 08:00AM
Dec 23, 2025 04:31PM
Dec 23, 2025 04:30PM Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Dec 23, 2025 04:30PM
Dec 10, 2025 04:30PM
Dec 10, 2025 04:30PM
Dec 9, 2025 08:30AM
Dec 9, 2025 08:30AM
Dec 4, 2025 08:37AM
Dec 4, 2025 08:37AM Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
Dec 1, 2025 12:08PM
Dec 1, 2025 12:00PM
Nov 25, 2025 08:00AM
Nov 21, 2025 08:37AM
Oct 21, 2025 04:30PM
Oct 21, 2025 04:30PM
Oct 21, 2025 08:01AM Citius Pharmaceuticals raises $6 million in registered direct offering
Oct 21, 2025 08:00AM
Oct 20, 2025 08:38AM
Oct 20, 2025 08:37AM
Oct 17, 2025 05:00PM
Oct 16, 2025 08:47AM
Oct 16, 2025 08:47AM
Oct 7, 2025 08:47AM Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe
Sep 10, 2025 04:30PM

326,538 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All